Monitor for actual execution on Form 4 and any upcoming pipeline catalysts that may offset selling pressure.
SEPN drugs
SEPN drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 29 $34.75entry
- T+1 · 5mo ago −3.63%α −4.40% · $33.49
- T+5 · 4mo ago −3.68%α −5.07% · $33.47
- T+20 · 4mo ago −4.75%α −4.47% · $33.10
- T+60 · 8w ago +16.20%α +11.82% · $40.38
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Jae B. Kim, an officer of Septerna, Inc., filed a Form 144 on June 26, 2026, indicating intent to sell 94,339 shares of common stock, with an approximate market value of $3.33 million based on the filing date. This is a non-urgent intent filing, but the sell size relative to recent insider activity carries negative signal.
Key Facts
- Form 144 filed by officer Jae B. Kim on 2026-06-26 for 94,339 shares of SEPN common stock.
- Estimated market value of proposed sale: approximately $3.33 million ($35.26 per share).
- Prior 30-day insider activity includes 3 sells totaling $547,000, so this filing more than quintuples known insider selling volume.
- Shares to be sold were acquired via employee stock purchase plans (10/31/2025 and 04/30/2026), not open-market buys.
Financial Impact
Proposed insider sale of ~$3.33M in SEPN stock (0.21% of $1.6B market cap).
Risk Factors
- Insider sale may signal reduced conviction ahead of key clinical or operational milestones.
- If sale executes, near-term technical overhang of ~94k shares could pressure the stock.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-006526 |
| Document: 0001950047-26-006526-index.html | 0001950047-26-006526 |
| Document: 0001950047-26-006526.txt | 0001950047-26-006526 |
Track record
25 reports on SEPN
6 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +55.96% at T+60 after the Apr 13, 2026 report. 7 of 7 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
- Nov 16, 2026today 144 Neutral 2/10 Entry price pending
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $42.60 Now $41.67 −2.18% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $42.60 Now $41.67 −2.18% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $41.86 Now $41.67 −0.45% settles Nov 19
- Nov 9, 20267d ago Press Release Bearish 5/10 Entry $52.34 Now $41.67 +20.39% settles Nov 17
- Nov 4, 202612d ago 8-K Neutral 3/10 Entry $47.88 to $48.56 Now $41.67 −12.97% ▲ +1.42% +2.33% vs SPY
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $47.88 to $48.56 Now $41.67 −12.97% ▲ +1.42% +2.33% vs SPY
- Sep 10, 20269w ago Press Release Neutral 2/10 Entry $38.51 to $38.69 Now $41.67 +8.21% ▲ +0.47% +0.69% vs SPY
- Sep 3, 202610w ago 3 Neutral 2/10 Entry $36.75 to $39.55 Now $41.67 +13.39% ▲ +7.62% +8.83% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers